Acute coronary disease in essential thrombocythemia and polycythemia vera

Journal of Internal Medicine

Volumn 244, Issue 1, 1998, Pages 49-53

  Rossi, C ^a   Randi, M L ^a,b   Zerbinati, P ^a   Rinaldi, V ^a   Girolami, A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Ospedale 105   (Italy)

Author keywords

Essential thrombocythemia; Myocardial infarction; Polycythemia vera

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYUREA;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTHEMIA; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; AGED; AGING; ANTISICKLING AGENTS; ASPIRIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHLEBOTOMY; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; POLYCYTHEMIA VERA; RISK FACTORS; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 0031877672     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00314.x     Document Type: Article

References (28)

1. Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1-12.
2. Murphy S, Hand H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin Hematol 1986; 23: 177-82.
3. Bellucci S, Janvier M, Tobelem G. Essential Thrombocythemia: clinical evolutionary and biological data. Cancer 1986; 58: 2440-47.
4. Epstein E, Goedel A. Hamorrhagische Thrombozythamie bei vaskularer Schrumpfmilz. Virchows Arch Pathol Anat 1934; 292: 233-48.
5. Gunz FW. A critical review. Blood 1960; 15: 706-23.
6. Silverstein MN. Primary or hemorrhagic thrombocythemia. Arch Intern Med 1968; 122: 18-22.
7. Preston FE. Essential thrombocythemia. Lancet 1982; 1: 1021.
8. Dawson AA, Ogston D. The influence of the platelet count on the incidence of thrombotic and hemorrhagic complications in polycythaemia vera. Postgrad Med J 1970; 46: 76-8.
9. Hoagland HC, Silverstein MN. Primary thrombocythemia in the young patients. Mayo Clin Proc 1978; 53: 578-80.
10. Randi ML, Fabris F, Girolami A. Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40. Blut 1990; 60: 233-7.
11. Cortellazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with thrombocythemia. J Clin Oncol 1990; 8: 556-62.
12. Lazlo J. Myeloproliferative disorders (MPD): Myelofibrosis. myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 1975; 12: 409-32.
13. Hehlmann R, Jahn M, Baumann B, Kopcke W. Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 1988; 61: 2487-96.
14. McIntyre KJ, Hoagland HC, Silverstein MN, Petit RM. Essential thrombocythemia in young adults. Mayo Clin Proc 1991; 66: 149-54.
15. Virmani R, Popovsky MA, Roberts WC. Thrombocytosis, coronary thrombosis and acute myocardial infarction. Am J Med 1979; 67: 498-505.
16. Scheffer MG, Michiels JJ, Simoons ML, Roelandt JRTC. Thrombocythemia and coronary artery disease. Am Heart J 1991; 122: 573-6.
17. Randi ML, Fabris F, Varotto L, Simioni P, Girolami A. Acute coronary disease in polycythemia vera and in essential thrombocytosis. In: Lenzi S and Descovich GC, eds. Atherosclerosis and Cardiovascular Disease, Bologna: Editrice Compositori, 1987: 553-7.
18. Douste-Blazy P, Taudou MJ, Delay M, Pris J, Sie P, Ribaut L et al. Essential thrombocythemia and recurrent myocardial infarction. Lancet 1984; 2: 992.
19. Berlin NI. Diagnosis and classification of polycythemias. Semin Haematol 1975; 12: 339-51.
20. Fabris F, Randi ML, Casonato A, Dal Bò Zanon R, Bonvicini P, Girolami A. Clinical significance of beta-thromboglobulin in patients with high platelet count. Acta Haematol 1984; 71: 32-8.
21. Hoffman R, Silverstein MN. Polycythemia vera. In: Hoffman R. Hematology: Basic Principles and Practice. New York: Churchill Livingstone, 1991: 834-54.
22. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 310-18.
23. Millard EF, Hunter CS, Anderson M, Edelman MJ, Kosty MP, Luiken GA et al. Clinical manifestations of essential thrombocythemia in young adults. Am J Hematol 1990; 33: 27-31.
24. Richard B, Davis MD. Acute thrombotic complications of myeloproliferative disorders in young adults. Am J Clin Path 1985; 2: 180-85.
25. Watson VK, Key N. Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors. Br J Haematol 1993; 83: 198-203.
26. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 1986; 23: 132-43.
27. Pearson TC, Wethereley-Mein G. Vascular occlusive episodes and venous hematocrit in primary proliferative polycythemia. Lancet 1978; 2: 1219-22.
28. Tartaglia AP, Goldberg JD, Berk PD, Wasserman LR. Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Semin Hematol 1986; 23: 172-6.